Eversept Partners

Latest statistics and disclosures from Eversept Partners's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Eversept Partners, LLC consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Eversept Partners

Companies in the Eversept Partners portfolio as of the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Horizon Therapeutics Pub L SHS (HZNP) 10.6 $47M -36% 608k 77.68
Amarin Corp Spons Adr New (AMRN) 10.1 $45M +122% 11M 4.21
Tg Therapeutics (TGTX) 6.2 $27M -59% 1.0M 26.76
Ascendis Pharma A/s Sponsored Adr (ASND) 5.6 $25M -26% 161k 154.32
United Therapeutics Corporation (UTHR) 5.5 $24M +3% 241k 101.00
Teva Pharmaceutical Inds Sponsored Ads (TEVA) 4.9 $22M NEW 2.4M 9.01
Fate Therapeutics (FATE) 4.8 $21M 535k 39.97
Biohaven Pharmaceutical Holding (BHVN) 4.7 $21M -28% 322k 65.01
Deciphera Pharmaceuticals (DCPH) 4.6 $21M -3% 402k 51.30
Ensign (ENSG) 4.1 $18M -25% 319k 57.11
Heska Corp Com Restrc New (HSKA) 3.5 $16M -43% 159k 98.79
Zogenix Com New (ZGNX) 3.5 $16M -14% 865k 17.93
Catalent (CTLT) 2.7 $12M NEW 140k 85.66
OraSure Technologies (OSUR) 2.6 $11M NEW 940k 12.17

Setup an alert

Eversept Partners will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Amneal Pharmaceuticals Com Stk Cl A (AMRX) 2.3 $10M +199% 2.7M 3.88
D Fluidigm Corp Del (FLDM) 2.2 $9.7M +178% 1.3M 7.43
Qiagen Nv Shs New (QGEN) 2.0 $8.8M +103% 168k 52.26
Taro Pharmaceutical Inds SHS (TARO) 1.8 $7.8M +34% 142k 54.85
Danaher Corporation (DHR) 1.5 $6.8M -70% 31k 215.50
Model N (MODN) 1.5 $6.7M -44% 189k 35.28
Hca Holdings (HCA) 1.5 $6.5M +72% 52k 124.68
Aurinia Pharmaceuticals (AUPH) 1.4 $6.4M -20% 436k 14.73
Momenta Pharmaceuticals 1.2 $5.2M -20% 99k 52.48
Mylan Nv Shs Euro (MYL) 1.1 $4.8M NEW 325k 14.83
Intra Cellular Therapies (ITCI) 1.0 $4.5M NEW 177k 25.66
Affimed Therapeutics B V (AFMD) 0.9 $4.2M +32% 1.2M 3.39
BioCryst Pharmaceuticals (BCRX) 0.9 $3.9M -76% 1.1M 3.44
Oxford Immunotec Global Ord Shs (OXFD) 0.8 $3.4M -16% 293k 11.70
Astrazeneca Sponsored Adr (AZN) 0.8 $3.3M -89% 61k 54.80
Mersana Therapeutics (MRSN) 0.6 $2.6M NEW 140k 18.62
Sanofi Sponsored Adr (SNY) 0.6 $2.5M 50k 50.16
Glaxosmithkline Sponsored Adr (GSK) 0.6 $2.5M -71% 64k 38.11
Apellis Pharmaceuticals (APLS) 0.6 $2.5M -80% 81k 30.17
Celldex Therapeutics Com New (CLDX) 0.5 $2.2M -78% 151k 14.83
Sesen Bio (SESN) 0.5 $2.2M -22% 1.6M 1.40
Quidel Corporation (QDEL) 0.5 $2.0M NEW 9.3k 219.42
Prothena Corp SHS (PRTA) 0.4 $2.0M +29% 197k 9.99
Otonomy (OTIC) 0.4 $1.7M -31% 413k 4.05
Kalvista Pharmaceuticals (KALV) 0.3 $1.4M +19% 107k 12.59
Concert Pharmaceuticals I equity (CNCE) 0.2 $1.0M -55% 104k 9.82
Liquidia Technologies (LQDA) 0.2 $899k -78% 183k 4.92
Solid Biosciences (SLDB) 0.1 $623k -24% 307k 2.03
Protara Therapeutics Com Stk (TARA) 0.1 $611k -21% 36k 16.83
Amarin Corp Call 0.1 $504k +18% 13k 39.21
Scpharmaceuticals (SCPH) 0.1 $489k -73% 66k 7.45
Sarepta Therapeutics (SRPT) 0.1 $266k -97% 1.9k 140.22
Teligent Com New (TLGT) 0.0 $220k -13% 305k 0.72
Gohealth Com Cl A 0.0 $171k NEW 13k 13.02

Past Filings by Eversept Partners

SEC 13F filings are viewable for Eversept Partners going back to 2017